 Roy Parker
Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytoplasmic Granules | 16 | 2024 | 93 | 8.050 |
Why?
| | Ribonucleoproteins | 14 | 2024 | 105 | 5.770 |
Why?
| | RNA | 13 | 2025 | 921 | 3.990 |
Why?
| | tau Proteins | 5 | 2025 | 90 | 3.470 |
Why?
| | RNA-Binding Proteins | 12 | 2025 | 422 | 2.970 |
Why?
| | RNA Stability | 11 | 2024 | 117 | 2.880 |
Why?
| | RNA, Messenger | 18 | 2024 | 2834 | 2.760 |
Why?
| | Saccharomyces cerevisiae | 6 | 2020 | 557 | 2.430 |
Why?
| | Tauopathies | 3 | 2025 | 13 | 2.240 |
Why?
| | Protein Aggregation, Pathological | 4 | 2025 | 21 | 2.220 |
Why?
| | Exoribonucleases | 4 | 2023 | 49 | 2.090 |
Why?
| | Stress, Physiological | 7 | 2025 | 443 | 2.060 |
Why?
| | Protein Aggregates | 2 | 2025 | 72 | 1.790 |
Why?
| | RNA, Fungal | 4 | 2020 | 72 | 1.790 |
Why?
| | Dyskeratosis Congenita | 4 | 2023 | 7 | 1.640 |
Why?
| | Eukaryotic Cells | 6 | 2019 | 40 | 1.590 |
Why?
| | RNA, Double-Stranded | 4 | 2024 | 57 | 1.410 |
Why?
| | Transcriptome | 4 | 2024 | 972 | 1.380 |
Why?
| | Cell Nucleus | 3 | 2025 | 620 | 1.380 |
Why?
| | Virus Replication | 4 | 2024 | 483 | 1.240 |
Why?
| | Eukaryotic Initiation Factor-2 | 2 | 2019 | 29 | 1.180 |
Why?
| | Intrinsically Disordered Proteins | 3 | 2018 | 34 | 1.150 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2020 | 405 | 1.100 |
Why?
| | DEAD-box RNA Helicases | 4 | 2024 | 76 | 1.090 |
Why?
| | MicroRNAs | 4 | 2023 | 692 | 1.060 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2023 | 528 | 1.050 |
Why?
| | RNA Viruses | 2 | 2019 | 43 | 1.030 |
Why?
| | Peptide Chain Initiation, Translational | 2 | 2019 | 44 | 1.030 |
Why?
| | Amyloid | 2 | 2018 | 87 | 1.010 |
Why?
| | Neurodegenerative Diseases | 3 | 2025 | 135 | 1.010 |
Why?
| | RNA Processing, Post-Transcriptional | 3 | 2025 | 92 | 0.980 |
Why?
| | Retinoblastoma Protein | 1 | 2025 | 57 | 0.950 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2025 | 29 | 0.930 |
Why?
| | Myotonic Dystrophy | 1 | 2025 | 10 | 0.930 |
Why?
| | Coiled Bodies | 1 | 2025 | 8 | 0.920 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2025 | 121 | 0.920 |
Why?
| | Protein Biosynthesis | 4 | 2019 | 433 | 0.890 |
Why?
| | Endoribonucleases | 3 | 2021 | 81 | 0.880 |
Why?
| | RNA Helicases | 2 | 2024 | 30 | 0.870 |
Why?
| | Cell Nucleus Structures | 1 | 2023 | 4 | 0.850 |
Why?
| | RNA, Untranslated | 2 | 2023 | 124 | 0.840 |
Why?
| | Alzheimer Disease | 2 | 2021 | 560 | 0.840 |
Why?
| | Animals | 26 | 2025 | 36951 | 0.840 |
Why?
| | HeLa Cells | 6 | 2024 | 636 | 0.820 |
Why?
| | Cell Hypoxia | 1 | 2024 | 226 | 0.820 |
Why?
| | Gene Expression Regulation | 5 | 2025 | 2607 | 0.810 |
Why?
| | Viral Load | 3 | 2021 | 469 | 0.790 |
Why?
| | Viruses | 1 | 2024 | 113 | 0.780 |
Why?
| | Organelles | 3 | 2020 | 58 | 0.770 |
Why?
| | Telomerase | 2 | 2022 | 250 | 0.760 |
Why?
| | Virus Diseases | 1 | 2024 | 212 | 0.720 |
Why?
| | RNA, Small Nucleolar | 1 | 2021 | 9 | 0.710 |
Why?
| | 3' Untranslated Regions | 2 | 2019 | 145 | 0.710 |
Why?
| | Humans | 43 | 2025 | 137782 | 0.700 |
Why?
| | Carrier Proteins | 1 | 2024 | 771 | 0.670 |
Why?
| | Influenza A virus | 1 | 2021 | 107 | 0.660 |
Why?
| | Eukaryotic Initiation Factor-4A | 1 | 2020 | 5 | 0.660 |
Why?
| | Eukaryotic Initiation Factor-4F | 1 | 2020 | 3 | 0.660 |
Why?
| | Muscular Diseases | 1 | 2020 | 114 | 0.660 |
Why?
| | RNA Splicing | 3 | 2021 | 269 | 0.650 |
Why?
| | Muscle Development | 1 | 2020 | 111 | 0.650 |
Why?
| | Macrophages | 2 | 2025 | 1549 | 0.640 |
Why?
| | RNA Virus Infections | 1 | 2019 | 15 | 0.640 |
Why?
| | eIF-2 Kinase | 1 | 2019 | 31 | 0.630 |
Why?
| | Prostaglandin D2 | 1 | 2019 | 23 | 0.610 |
Why?
| | Interferon-beta | 1 | 2019 | 92 | 0.610 |
Why?
| | TDP-43 Proteinopathies | 1 | 2018 | 6 | 0.600 |
Why?
| | Neuromuscular Diseases | 1 | 2020 | 132 | 0.600 |
Why?
| | Cellular Reprogramming | 1 | 2019 | 99 | 0.590 |
Why?
| | Open Reading Frames | 1 | 2018 | 123 | 0.570 |
Why?
| | Vault Ribonucleoprotein Particles | 1 | 2017 | 1 | 0.560 |
Why?
| | Protein Binding | 6 | 2025 | 2224 | 0.560 |
Why?
| | Single Molecule Imaging | 1 | 2017 | 37 | 0.550 |
Why?
| | Macromolecular Substances | 1 | 2018 | 229 | 0.540 |
Why?
| | Ribosomes | 2 | 2018 | 186 | 0.530 |
Why?
| | RNA Caps | 1 | 2016 | 35 | 0.520 |
Why?
| | Regeneration | 1 | 2018 | 197 | 0.510 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2017 | 317 | 0.510 |
Why?
| | Mass Screening | 3 | 2021 | 1288 | 0.500 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2016 | 22 | 0.500 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 465 | 0.500 |
Why?
| | Cell Line, Tumor | 6 | 2025 | 3415 | 0.490 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2015 | 8 | 0.490 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 539 | 0.490 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2019 | 257 | 0.480 |
Why?
| | Inflammation | 2 | 2024 | 2838 | 0.470 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2015 | 73 | 0.470 |
Why?
| | Nervous System Diseases | 1 | 2018 | 266 | 0.460 |
Why?
| | Viroids | 1 | 2014 | 3 | 0.460 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 168 | 0.460 |
Why?
| | RNA-Binding Protein FUS | 1 | 2014 | 13 | 0.460 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2014 | 18 | 0.460 |
Why?
| | RNA, Viral | 2 | 2019 | 656 | 0.450 |
Why?
| | RNA, Small Nuclear | 1 | 2014 | 37 | 0.440 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2014 | 50 | 0.430 |
Why?
| | Phosphorylation | 3 | 2025 | 1759 | 0.390 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1775 | 0.380 |
Why?
| | Mice | 7 | 2025 | 17794 | 0.380 |
Why?
| | Drosophila Proteins | 1 | 2014 | 204 | 0.380 |
Why?
| | Muscle, Skeletal | 2 | 2020 | 1724 | 0.380 |
Why?
| | Drosophila melanogaster | 1 | 2014 | 233 | 0.380 |
Why?
| | Protein Folding | 3 | 2018 | 280 | 0.360 |
Why?
| | Active Transport, Cell Nucleus | 3 | 2018 | 124 | 0.360 |
Why?
| | Proteome | 1 | 2016 | 472 | 0.350 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1502 | 0.350 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2025 | 218 | 0.340 |
Why?
| | Models, Biological | 5 | 2019 | 1783 | 0.340 |
Why?
| | Mutation | 5 | 2022 | 3959 | 0.320 |
Why?
| | Cytosol | 2 | 2021 | 226 | 0.320 |
Why?
| | Polyadenylation | 2 | 2020 | 42 | 0.310 |
Why?
| | Cell Survival | 2 | 2025 | 1120 | 0.310 |
Why?
| | Neurons | 1 | 2018 | 1590 | 0.300 |
Why?
| | Mammals | 2 | 2022 | 283 | 0.290 |
Why?
| | Protein Interaction Maps | 2 | 2018 | 48 | 0.280 |
Why?
| | HEK293 Cells | 2 | 2021 | 730 | 0.280 |
Why?
| | Models, Theoretical | 2 | 2021 | 578 | 0.270 |
Why?
| | Antiviral Agents | 2 | 2024 | 744 | 0.260 |
Why?
| | Nuclear Proteins | 2 | 2022 | 712 | 0.240 |
Why?
| | Ribosome Subunits, Large, Eukaryotic | 1 | 2025 | 3 | 0.230 |
Why?
| | RNA Recognition Motif Proteins | 1 | 2024 | 4 | 0.230 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2024 | 35 | 0.230 |
Why?
| | Polymerase Chain Reaction | 2 | 2021 | 1062 | 0.230 |
Why?
| | Ribosomal Proteins | 1 | 2025 | 93 | 0.220 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1356 | 0.220 |
Why?
| | Drosophila | 1 | 2025 | 154 | 0.220 |
Why?
| | Asymptomatic Infections | 2 | 2021 | 30 | 0.220 |
Why?
| | Cell Nucleolus | 1 | 2023 | 17 | 0.210 |
Why?
| | Protein Domains | 1 | 2025 | 289 | 0.210 |
Why?
| | Loss of Function Mutation | 1 | 2023 | 46 | 0.210 |
Why?
| | DNA Helicases | 1 | 2024 | 145 | 0.200 |
Why?
| | Molecular Chaperones | 1 | 2024 | 195 | 0.200 |
Why?
| | Mitosis | 1 | 2024 | 192 | 0.200 |
Why?
| | Molecular Docking Simulation | 1 | 2023 | 114 | 0.200 |
Why?
| | Neutropenia | 1 | 2023 | 146 | 0.200 |
Why?
| | Virion | 2 | 2021 | 93 | 0.190 |
Why?
| | Cell Cycle | 1 | 2025 | 601 | 0.190 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5764 | 0.180 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2024 | 430 | 0.180 |
Why?
| | Time Factors | 3 | 2021 | 6834 | 0.180 |
Why?
| | Biology | 1 | 2022 | 88 | 0.180 |
Why?
| | High-Throughput Screening Assays | 1 | 2023 | 158 | 0.180 |
Why?
| | Nidovirales | 1 | 2020 | 1 | 0.170 |
Why?
| | Orthoreovirus | 1 | 2020 | 6 | 0.170 |
Why?
| | Limit of Detection | 1 | 2021 | 85 | 0.170 |
Why?
| | Communicable Disease Control | 1 | 2021 | 82 | 0.170 |
Why?
| | Carrier State | 1 | 2021 | 67 | 0.170 |
Why?
| | Lizards | 1 | 2020 | 35 | 0.170 |
Why?
| | Calibration | 1 | 2021 | 146 | 0.170 |
Why?
| | Reoviridae Infections | 1 | 2020 | 54 | 0.170 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 801 | 0.170 |
Why?
| | Kinetics | 2 | 2021 | 1670 | 0.160 |
Why?
| | Mice, Transgenic | 1 | 2025 | 2167 | 0.160 |
Why?
| | Time-Lapse Imaging | 1 | 2020 | 21 | 0.160 |
Why?
| | Vero Cells | 1 | 2019 | 69 | 0.160 |
Why?
| | Epidemics | 1 | 2021 | 89 | 0.160 |
Why?
| | A549 Cells | 1 | 2019 | 66 | 0.160 |
Why?
| | Protein Transport | 1 | 2021 | 445 | 0.160 |
Why?
| | Telomere | 1 | 2022 | 280 | 0.160 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1457 | 0.150 |
Why?
| | Coinfection | 1 | 2020 | 137 | 0.150 |
Why?
| | RNA Nucleotidyltransferases | 1 | 2019 | 21 | 0.150 |
Why?
| | Ribonucleases | 1 | 2019 | 55 | 0.150 |
Why?
| | Cell Tracking | 1 | 2019 | 17 | 0.150 |
Why?
| | HCT116 Cells | 1 | 2019 | 80 | 0.150 |
Why?
| | Ribonuclease III | 1 | 2019 | 40 | 0.150 |
Why?
| | Alternative Splicing | 1 | 2020 | 229 | 0.150 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 325 | 0.150 |
Why?
| | Genome, Viral | 1 | 2019 | 144 | 0.150 |
Why?
| | Etoposide | 1 | 2019 | 158 | 0.150 |
Why?
| | Viral Proteins | 1 | 2021 | 342 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 617 | 0.150 |
Why?
| | Sarcomeres | 1 | 2018 | 96 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 593 | 0.140 |
Why?
| | Cytoplasm | 1 | 2018 | 274 | 0.140 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2018 | 89 | 0.140 |
Why?
| | Prevalence | 2 | 2021 | 2734 | 0.140 |
Why?
| | Metagenomics | 2 | 2020 | 169 | 0.140 |
Why?
| | Disease Progression | 1 | 2025 | 2760 | 0.130 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 491 | 0.130 |
Why?
| | Hypoxia | 1 | 2024 | 1112 | 0.130 |
Why?
| | Doxorubicin | 1 | 2019 | 363 | 0.130 |
Why?
| | Walker-Warburg Syndrome | 1 | 2016 | 1 | 0.130 |
Why?
| | Mallory Bodies | 1 | 2016 | 1 | 0.130 |
Why?
| | NAD | 1 | 2016 | 77 | 0.130 |
Why?
| | Dwarfism | 1 | 2016 | 17 | 0.130 |
Why?
| | Osteochondrodysplasias | 1 | 2016 | 18 | 0.130 |
Why?
| | Computer Simulation | 1 | 2021 | 982 | 0.120 |
Why?
| | Sodium Azide | 1 | 2016 | 5 | 0.120 |
Why?
| | Muscular Dystrophies | 1 | 2016 | 36 | 0.120 |
Why?
| | Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 2015 | 5 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1946 | 0.120 |
Why?
| | Yeasts | 1 | 2016 | 53 | 0.120 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2016 | 69 | 0.120 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2015 | 20 | 0.120 |
Why?
| | Hair | 1 | 2016 | 86 | 0.120 |
Why?
| | Rabbits | 1 | 2017 | 794 | 0.120 |
Why?
| | Molecular Mimicry | 1 | 2015 | 42 | 0.120 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2015 | 27 | 0.120 |
Why?
| | RNA Precursors | 1 | 2016 | 154 | 0.120 |
Why?
| | Disease | 1 | 2016 | 98 | 0.120 |
Why?
| | Neuronal Plasticity | 1 | 2018 | 290 | 0.120 |
Why?
| | Microcephaly | 1 | 2016 | 98 | 0.120 |
Why?
| | Solutions | 1 | 2015 | 168 | 0.120 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2016 | 188 | 0.120 |
Why?
| | Hirschsprung Disease | 1 | 2016 | 88 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2017 | 452 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2025 | 4295 | 0.110 |
Why?
| | Sodium Chloride | 1 | 2015 | 142 | 0.110 |
Why?
| | RNA Splice Sites | 1 | 2014 | 45 | 0.110 |
Why?
| | Survival of Motor Neuron 1 Protein | 1 | 2014 | 12 | 0.110 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2014 | 24 | 0.110 |
Why?
| | Contig Mapping | 1 | 2014 | 11 | 0.110 |
Why?
| | Alleles | 1 | 2017 | 892 | 0.110 |
Why?
| | NIH 3T3 Cells | 1 | 2014 | 144 | 0.110 |
Why?
| | Lung Diseases, Interstitial | 1 | 2020 | 642 | 0.110 |
Why?
| | Quality Control | 1 | 2014 | 172 | 0.110 |
Why?
| | Water Microbiology | 1 | 2014 | 85 | 0.100 |
Why?
| | Introns | 1 | 2014 | 258 | 0.100 |
Why?
| | Scoliosis | 1 | 2016 | 215 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2014 | 327 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.100 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 861 | 0.100 |
Why?
| | DNA Repair | 1 | 2014 | 231 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1396 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3290 | 0.100 |
Why?
| | Repressor Proteins | 1 | 2016 | 427 | 0.100 |
Why?
| | Antibodies | 1 | 2014 | 410 | 0.090 |
Why?
| | Blotting, Western | 1 | 2014 | 1227 | 0.090 |
Why?
| | Nucleic Acid Conformation | 1 | 2014 | 728 | 0.090 |
Why?
| | Models, Genetic | 1 | 2014 | 600 | 0.090 |
Why?
| | Escherichia coli | 1 | 2015 | 815 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 812 | 0.090 |
Why?
| | Fetal Growth Retardation | 1 | 2016 | 566 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1502 | 0.080 |
Why?
| | Base Sequence | 1 | 2014 | 2181 | 0.080 |
Why?
| | Oxidative Stress | 1 | 2017 | 1317 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2016 | 498 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2015 | 641 | 0.080 |
Why?
| | Phenotype | 1 | 2017 | 3196 | 0.080 |
Why?
| | Female | 4 | 2021 | 73465 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2129 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 4154 | 0.060 |
Why?
| | Signal Transduction | 1 | 2019 | 5081 | 0.060 |
Why?
| | Male | 3 | 2021 | 67906 | 0.060 |
Why?
| | Macrophage Activation | 1 | 2025 | 201 | 0.050 |
Why?
| | Animals, Zoo | 1 | 2020 | 12 | 0.040 |
Why?
| | Neoplasms | 1 | 2014 | 2673 | 0.040 |
Why?
| | Saliva | 1 | 2021 | 244 | 0.040 |
Why?
| | Immunity, Innate | 1 | 2025 | 828 | 0.040 |
Why?
| | Universities | 1 | 2021 | 433 | 0.040 |
Why?
| | Luminescent Proteins | 1 | 2019 | 179 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2019 | 390 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2020 | 395 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 2200 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4576 | 0.020 |
Why?
|
|
Parker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|